TG Therapeutics, Inc. (TGTX) Earnings
|
Expand Research on TGTX
| Next EPS Date | 11/9/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +218.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/9/26  |
Q326 | N/A | $0.37 | N/A | N/A | $247.06M | = | N/A | N/A | ||
| 8/10/26 |
Q226 | N/A | $0.33 | N/A | N/A | $228.5M | = | N/A | N/A | ||
| 5/6/26 | Q126 | $0.12 | $0.28 | -$0.16 | $194.8M | $199.45M | = |  | | Details | |
| 2/26/26 | Q425 | $0.14 | $0.37 | -$0.23 | $192.57M | $188.73M | = | | | Details | |
| 11/3/25 | Q325 | $2.43 | $0.22 | +$2.21 | $161.7M | $152.23M | = | | | Details | |
| 10/30/25 |
Q325 | N/A | $0.22 | N/A | N/A | $152.23M | = | N/A | N/A | ||
| 8/4/25 | Q225 | $0.17 | $0.19 | -$0.02 | $141.1M | $137.4M | = | | | Details | |
| 5/5/25 | Q125 | $0.03 | $0.16 | -$0.13 | $119.7M | $117.13M | = | | | Details |
